Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
Pharma News, Views & Analysis
Filter
News
Articles
Podcasts
Infographics
Advertise With Us
Advertise With Us
Respiratory infections cost UK businesses £44bn annually
A new report by the Office of Health Economics (OHE), commissioned by Pfizer, reveals that respiratory infections can be bad for business.
Read more
BioMarin supports haemophilia documentary initiative
A new filmmaking project is sponsored by BioMarin Pharmaceutical to support people with haemophilia, exploring the healing and therapeutic power of arts and self expression.
FDA approves first-in-class cancer checkpoint inhibitor
A new type of checkpoint inhibitor to treat unresectable or metastatic melanoma has been approved by the FDA.
Industry welcomes UK-wide commitment to genomic research
Better genomic testing and access to clinical trials have been prioritised and agreed by the UK government and devolved administrations. Read for more details.
Treatment milestone for diabetes in pregnancy
After positive study results, metformin-based anti-diabetic medication from Merck has received a label extension for use throughout pregnancy. Find out more.
Rare disease action plan published
A new action plan for rare diseases has been published by the Department of Health and Social Care to mark Rare Diseases Day.
Spoonful of apps
GOLD showcases some standout apps created, or harnessed by, the pharma industry.
Sanofi and GSK seek COVID-19 vaccine approval
Sanofi and GSK are seeking regulatory approval for their adjuvanted protein-based COVID-19 vaccine, as a primary two-dose series and booster dose.
Spoonful of technology: February 2023
GOLD reviews the top stories in health technology from the past few months, highlighting how tech is changing treatment landscapes and patient experiences.
Loading posts...
« Previous
1
…
16
17
18
19
Next »